Myeloproliferative Neoplasms News

More than a year into the COVID-19 pandemic, new information emerges daily about the virus and its effects on various vulnerable populations.

Poly(ADP-ribose) polymerase, or PARP, inhibitors appeared associated with increased risk for secondary myelodysplastic syndrome and acute myeloid leukemia compared with placebo among patients with cancer, according to study results.

The Leukemia & Lymphoma has collaborated with cancer institutions, foundations and philanthropic individuals to fund several cancer research projects.

Sitagliptin significantly reduced incidence of acute graft-versus-host disease after myeloablative allogeneic peripheral blood stem cell transplantation, according to phase 2 study results published in The New England Journal of Medicine.

This year’s virtual ASH Annual Meeting and Exposition featured hundreds of abstracts that spotlighted research advances in blood cancer and benign hematology research.

Two physicians who specialize in the treatment of patients with myeloproliferative neoplasms have been named 2020 MPN Heroes by Voices of MPN, an education and awareness initiative developed by Incyte.

Venetoclax plus azacitidine showed an acceptable safety profile and promising efficacy in older patients with high-risk myelodysplastic syndrome, according to phase 1 data presented at the ASH Annual Meeting and Exposition.

Patients acquired myeloproliferative neoplasm driver mutations early in life, often in utero, which then expanded at variable rates over their lifetime before diagnosis, according to study results.

Allogeneic hematopoietic cell transplantation improved overall survival and leukemia-free survival in patients aged 50 to 75 years with high-risk myelodysplastic syndrome, according to data presented at ASH Annual Meeting and Exposition.

Despite promising data that have emerged on COVID-19 vaccine candidates, a return to normal “carefree” life is likely years out, according to Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases.